Published in Neurobiol Aging on October 23, 2002
Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease. J Nutr Biochem (2008) 1.25
Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety. Oxid Med Cell Longev (2010) 0.97
Protective effects of quercetin on liver injury induced by ethanol. Pharmacogn Mag (2010) 0.89
Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract. J Nutr Biochem (2009) 0.88
Wine polyphenols: potential agents in neuroprotection. Oxid Med Cell Longev (2012) 0.87
Anthocyanins: are they beneficial in treating ethanol neurotoxicity? Neurotox Res (2009) 0.85
Anti-aging effects of some selected Iranian folk medicinal herbs-biochemical evidences. Iran J Basic Med Sci (2013) 0.79
Parkia biglobosa improves mitochondrial functioning and protects against neurotoxic agents in rat brain hippocampal slices. Biomed Res Int (2014) 0.77
Antiapoptotic Effects of EGb 761. Evid Based Complement Alternat Med (2013) 0.77
Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine. Can Vet J (2008) 0.76
Utility of nutraceutical products marketed for cognitive and memory enhancement. J Holist Nurs (2005) 0.75
Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases. Pharmaceuticals (Basel) (2009) 0.75
Phytochemical approach and bioanalytical strategy to develop chaperone-based medications. Open Biochem J (2008) 0.75
Anthoxanthin Polyphenols Attenuate Aβ Oligomer-induced Neuronal Responses Associated with Alzheimer's Disease. CNS Neurosci Ther (2016) 0.75
Correlation between antibutyrylcholinesterasic and antioxidant activities of three aqueous extracts from Tunisian Rhus pentaphyllum. Ann Clin Microbiol Antimicrob (2011) 0.75
Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol (2002) 2.03
Psychosis pathways converge via D2high dopamine receptors. Synapse (2006) 1.78
The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev (2002) 1.41
Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol (2004) 1.35
Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival. J Neurochem (2004) 1.33
Apoptosis-inducing factor: a matter of neuron life and death. Prog Neurobiol (2007) 1.31
A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology (Berl) (2003) 1.23
Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. J Neurosci (2010) 1.21
Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. Eur J Neurosci (2006) 1.20
FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J Neurochem (2002) 1.18
A microdialysis profile of Met-enkephalin release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res (2005) 1.11
Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav Brain Res (2003) 1.09
Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci (2005) 1.09
Successful cognitive aging in rats: a role for mGluR5 glutamate receptors, homer 1 proteins and downstream signaling pathways. PLoS One (2012) 1.07
The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology (2002) 1.04
A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res (2006) 1.04
Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets (2007) 1.03
A possible role of neuropeptide Y in depression and stress. Brain Res (2009) 1.02
Estrogen effects on object memory and cholinergic receptors in young and old female mice. Neurobiol Aging (2001) 1.02
Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA. J Neurosci (2004) 1.01
Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur J Pharmacol (2002) 0.99
Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells. BMC Neurosci (2006) 0.99
Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Neurobiol Dis (2009) 0.98
cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease. Pharmacol Ther (2003) 0.97
Does COX2-dependent PGE2 play a role in neuropathic pain? Neurosci Lett (2008) 0.96
Glutamate acting on N-methyl-D-aspartate receptors attenuates insulin-like growth factor-1 receptor tyrosine phosphorylation and its survival signaling properties in rat hippocampal neurons. J Biol Chem (2008) 0.95
Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells. Br J Pharmacol (2003) 0.95
α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling. J Neurochem (2011) 0.95
Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Life Sci (2002) 0.95
Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing. J Mol Neurosci (2004) 0.95
Transthyretin: a key gene involved in the maintenance of memory capacities during aging. Neurobiol Aging (2007) 0.94
Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites. PLoS One (2010) 0.92
Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat. J Chem Neuroanat (2009) 0.92
Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease. Biomaterials (2010) 0.92
Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease. Eur J Neurosci (2013) 0.91
Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J Pharmacol Exp Ther (2006) 0.90
Insulin-like growth factor 1 prevents neuronal cell death induced by corticosterone through activation of the PI3k/Akt pathway. J Neurosci Res (2004) 0.89
Effect of Mas-related gene (Mrg) receptors on hyperalgesia in rats with CFA-induced inflammation via direct and indirect mechanisms. Br J Pharmacol (2013) 0.89
Role of central calcitonin gene-related peptide (CGRP) in locomotor and anxiety- and depression-like behaviors in two mouse strains exhibiting a CGRP-dependent difference in thermal pain sensitivity. J Mol Neurosci (2009) 0.89
Modulation of NMDA receptors by intrathecal administration of the sensory neuron-specific receptor agonist BAM8-22. Neuropharmacology (2007) 0.88
Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model. J Alzheimers Dis (2012) 0.88
Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema. J Mol Neurosci (2007) 0.87
Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.87
Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex. J Neurochem (2004) 0.87
International perspectives on engaging the public in neuroethics. Nat Rev Neurosci (2005) 0.86
The involvement of spinal bovine adrenal medulla 22-like peptide, the proenkephalin derivative, in modulation of nociceptive processing. Eur J Neurosci (2007) 0.86
Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease. Neurobiol Aging (2006) 0.86
Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease. Am J Pathol (2010) 0.85
Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain. Front Pharmacol (2012) 0.85
Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABA(B) receptors in scopolamine-induced amnesia. J Neurochem (2007) 0.85
Comparative neuroprotective properties of stilbene and catechin analogs: action via a plasma membrane receptor site? CNS Neurosci Ther (2009) 0.84
Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions. J Neurochem (2004) 0.84
Reduction in acetylcholine release in the hippocampus of dopamine D5 receptor-deficient mice. Neuropsychopharmacology (2004) 0.84
βCTF-correlated burst of hippocampal TNFα occurs at a very early, pre-plaque stage in the TgCRND8 mouse model of Alzheimer's disease. J Alzheimers Dis (2013) 0.84
Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule. Exp Neurol (2010) 0.84
Amyloid beta peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology. Prog Brain Res (2004) 0.83
Estradiol valerate and alcohol intake: a comparison between Wistar and Lewis rats and the putative role of endorphins. Behav Brain Res (2003) 0.83
BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes. Br J Pharmacol (2005) 0.83
Aged neuropeptide Y transgenic rats are resistant to acute stress but maintain spatial and non-spatial learning. Behav Brain Res (2004) 0.83
Signaling pathways relevant to cognition-enhancing drug targets. Handb Exp Pharmacol (2015) 0.82
Upregulation of adrenomedullin in the spinal cord and dorsal root ganglia in the early phase of CFA-induced inflammation in rats. Pain (2009) 0.82
Gene expression profiling following chronic NMDA receptor blockade-induced learning deficits in rats. Synapse (2003) 0.82
Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neuropharmacology (2011) 0.82
Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8). Neurodegener Dis (2010) 0.81
Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice. J Mol Neurosci (2006) 0.81
Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test. Peptides (2005) 0.81
Proteomic approaches in brain research and neuropharmacology. Eur J Pharmacol (2004) 0.81
Systemic administration of kainic acid in adult rat stimulates expression of the chemokine receptor CCR5 in the forebrain. Glia (2002) 0.81
Neuropeptide Y receptor subtypes in the dorsal vagal complex under acute feeding adaptation in the adult rat. Neuropeptides (2009) 0.81
Adrenomedullin-2/intermedin induces cAMP accumulation in dissociated rat spinal cord cells: evidence for the existence of a distinct class of sites of action. J Mol Neurosci (2008) 0.81
Early environment contributes to developmental disruption of MPFC after neonatal ventral hippocampal lesions in rats. Synapse (2003) 0.81
Adrenomedullin receptor binding sites in rat brain and peripheral tissues. Eur J Pharmacol (2003) 0.80
Selective reduction in ventral hippocampal acetylcholine release in awake galanin-treated rats and galanin-overexpressing transgenic mice. Regul Pept (2004) 0.80
Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain. J Pharmacol Exp Ther (2005) 0.80
Targeting invading macrophage-derived PGE2, IL-6 and calcitonin gene-related peptide in injured nerve to treat neuropathic pain. Expert Opin Ther Targets (2006) 0.80
Morphological evidence for the involvement of microglial p38 activation in CGRP-associated development of morphine antinociceptive tolerance. Peptides (2010) 0.80
Neuroprotective effects of natural products: interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin. Neurochem Res (2007) 0.80
Loss of quinone reductase 2 function selectively facilitates learning behaviors. J Neurosci (2010) 0.80
An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization. EXS (2006) 0.79
An organelle proteomic method to study neurotransmission-related proteins, applied to a neurodevelopmental model of schizophrenia. Proteomics (2007) 0.79
Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation. BMC Neurosci (2006) 0.79
Immune marker CD68 correlates with cognitive impairment in normally aged rats. Neurobiol Aging (2013) 0.78
Possible role of dynorphins in Alzheimer's disease and age-related cognitive deficits. Neurodegener Dis (2013) 0.78
Knockdown of prodynorphin gene prevents cognitive decline, reduces anxiety, and rescues loss of group 1 metabotropic glutamate receptor function in aging. J Neurosci (2013) 0.78
The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer's disease. BMC Neurosci (2014) 0.78
Inhibition of SNL-induced upregulation of CGRP and NPY in the spinal cord and dorsal root ganglia by the 5-HT(2A) receptor antagonist ketanserin in rats. Pharmacol Biochem Behav (2012) 0.77
The common environmental pollutant dioxin-induced memory deficits by altering estrogen pathways and a major route of retinol transport involving transthyretin. Neurotoxicology (2008) 0.77
Aging and long-term caloric restriction regulate neuropeptide Y receptor subtype densities in the rat brain. Neuropeptides (2013) 0.77
Alterations in behavioral responses to a cholinergic agonist in post-pubertal rats with neonatal ventral hippocampal lesions: relationship to changes in muscarinic receptor levels. Neuropsychopharmacology (2005) 0.77
A role for protein kinase C-dependent upregulation of adrenomedullin in the development of morphine tolerance in male rats. J Neurosci (2010) 0.76
Involvement of PKA-dependent upregulation of nNOS-CGRP in adrenomedullin-initiated mechanistic pathway underlying CFA-induced response in rats. Exp Neurol (2012) 0.76
Clozapine administration reverses behavioral, neuronal, and nitric oxide disturbances in the neonatal ventral hippocampus rat. Neuropharmacology (2011) 0.76
Expression of apoptosis-inducing factor (AIF) in the aged rat brain. Neurobiol Aging (2009) 0.76
Alzheimer disease: advances in pathogenesis, diagnosis, and therapy. Clin Chem (2011) 0.76
Blockade of adrenomedullin receptors reverses morphine tolerance and its neurochemical mechanisms. Behav Brain Res (2011) 0.76
Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP. Neuropeptides (2004) 0.76
Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY. Br J Pharmacol (2003) 0.75
Modulation of sensory neuron-specific receptors in the development of morphine tolerance and its neurochemical mechanisms. J Neurosci Res (2010) 0.75
Notes from the guest editors. Healthc Pap (2004) 0.75